Vita-Max
Natural health product licensed in Canada
- Licence holder
- Lang Pharma Nutrition, Inc.
- NPN or DIN-HM
- 80000627
- Status
- Active licence
- Licence date
- 3 August 2005
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Magnésium: up to 350 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 300 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Magnésium: up to 350 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (250 mg a day). Pour ce nutriment, le repère de l'EFSA ne porte que sur les apports ajoutés (compléments, aliments enrichis), pas sur ce qu'apporte l'alimentation courante.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine E | 6.75 mg | 13,500 µg |
| Iode | 0.075 mg | 150 µg |
| Magnésium | 175 mg | 350,000 µg |
| Biotine | 150 mcg | 300 µg |
Non-medicinal ingredients
Carbonate de calcium, Stéarate de magnésium, Pharmaceutical Glaze, cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Multivitamin and mineral supplement
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you have impaired liver function. Discontinue use if you experience a prolonged flushing, burning, tingling or itching sensation on the face, arms or chest. Consult a health care practitioner prior to use if you are taking levodopa. Avoid using 2 hours prior to or until 4 hours after taking other medication. Consult a health care practitioner prior to use if you have a history of non-melanoma skin cancer. Consult a health care practitioner prior to use if you are taking tetracyclines.
- Contre-indications
Do not use if you have a copper storage or metabolism disorder, such as Wilson's disease.
Source
Official Health Canada record, licence 80000627
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.